冠状动脉支架术后施行非心脏手术的安全思考  

Thinking Deeply of Safe for Non-cardiac Surgery in Patients Inserted Coronary Artery Stent

作　　者：李雪艳[1] 都淑萍[1] 周承孝[1] 

机构地区：[1]威海市立医院,山东威海264200

出　　处：《中外医学研究》2017年第21期162-164,共3页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：冠状动脉支架术后采用抗血小板药物治疗的非心脏手术患者,常因术前停用抗血小板药物引发支架内栓塞,或应用抗血小板药物治疗发生过量出血等危险。本文旨在探讨抗血小板治疗的合理应用,以期减少相关并发症的发生。相关研究对手术患者安置冠脉支架的特性,抗血小板药物的合理应用及出、凝血并发症的预防等进行了评估。根据其研究结果,为减少术中、术后出血及支架内栓塞等并发症,应于围手术期采用超短效抗血小板药进行"搭桥"及血小板功能的监测。The non-cardiac surgery patients treated with antiplatelet drugs after coronary artery stenting are presenting in a dangerous situation of stent embolism because patients stop using the antiplatelet drugs or excessive bleeding during the treatment with antiplatelet drugs.This paper designs to discuss the reasonable application of the antiplatelet treatment, in order to reduce the occurrence of related complications.Correlational research evaluated characteristics of the surgical patients who were inserted coronary artery stents, the reasonable application of anti-platelet therapy, the prevention of complications like bleeding and blood coagulation.According to the results of them, treducethecmpicatinssuchasbeedingfintraperativeandpstperativeperidandstentembism the ＂bridging＂ with ultra shortly anti-platelet drugs shall be used and test platelet function closely in perioperative period.

关 键 词：冠状动脉支架 非心脏手术 抗血小板药物 并发症 预防 

分 类 号：R541.4[医药卫生—心血管疾病]